Showing results (171-180 of 337) with videos related to

Sort By:
Pageof 34
Investigational New Drugs|October 14, 2009
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myelomaJae-Cheol Jo, Byung Woog Kang, Sun Jin Sym, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatinJi-Youn Han, Hyeong-Seok Lim, Eun Soon Shin, et al.
American Journal of Clinical Oncology|April 8, 2006
A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancerDae Ho Lee, Ji-Youn Han, Seong Min Yoon, et al.
International Journal of Hematology|January 30, 2013
Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphomaChanghoon Yoo, Dok Hyun Yoon, Jeong Eun Kim, et al.
Journal of Cancer Research and Therapeutics|April 14, 2016
Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lungDong-Yeop Shin, Dae Ho Lee, Cheol Hyeon Kim, et al.
Endocrinology|February 23, 2012
Regulation of glucose transport by ROCK1 differs from that of ROCK2 and is controlled by actin polymerizationKwang-Hoon Chun, Kazushi Araki, Yuna Jee, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancerJi-Youn Han, Dae Ho Lee, Sung Young Lee, et al.
Cancer|January 18, 2006
Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinomaJi-Youn Han, Hyeong-Seok Lim, Dae Ho Lee, et al.
Cancer|November 19, 2005
Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinomaJi-Youn Han, Dae Ho Lee, Sung Young Lee, et al.
Japanese Journal of Clinical Oncology|October 18, 2006
A phase II trial of docetaxel plus capecitabine in patients with previously treated non-small cell lung cancerJae Jin Lee, Ji-Youn Han, Dae Ho Lee, et al.
Pageof 34